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Abstract Article Info 
Introduction: Nasopharyngeal carcinoma is (NPC) mostly found in men of productive age with a ratio of men 
and women 2,18: 1 and 60% of patients age between 25 and 60 years. NPCs are very rarely found in adolescents, 
namely age 11 to 21 years.  
Objective: To determine the characteristics of nasopharyngeal carcinoma in adolescent patients at ORL-HNS 
Department of Dr. Mohammad Hoesin General Hospital Palembang.  
Method: This is a descriptive retrospective study. The sample is all patients diagnosed with NPC in adolescence 
at ORL-HNS Department of Dr. Mohammad Hoesin General Hospital Palembang in January 2013 to December 
2017 period.  
Results: In this study, the number of adolescent NPC patients from January 2013 to December 2017 was 12 
patients. The majority of adolescent NPC patients were male (66,6%). The most common histopathological 
finding was WHO 2B (50%). Based on the T category, largely, the patients were T4 (41,6%). Most patients with 
Nodules were N3 (58,3%) and came to the ENT clinic were already in stage IV (41,6%).  
Conclusion: Adolescent nasopharyngeal carcinoma is more common in men than women (2: 1), and shows a 
response to proper therapy. 
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Nasopharyngeal carcinoma (NPC) has multifactorial etiology and 
risk factors, which is a combination of interactions between 
environmental, genetic, and Epstein-Barr Virus infections (EBV). 
Significant biological exposure in nasopharyngeal carcinogenesis is 
Epstein-Barr  Virus  (EBV)  infection which is characterized by an 
abnormal increase in viral capsid antibody-antigen of EBV and early 
EBV antigen. Various physical and chemical exposures that may lead to 
NPC are related to lifestyle, occupational, and environmental exposures 
include smoking, salted or preserved food and alcoholic beverages 
consumption, cigarette smoke, wood dust and so on. Evidence of the 
leading causes role such as various inhalant substances, herbal 
medicines and exposure in the workplace environment towards the 
incidence of NPC is still not consistent [1-5]. The world highest 
incidence of nasopharyngeal carcinoma is found in residents of the 
Southern China mainland, especially the Cantonese in Guangdong 
province and Guangxi region with numbers reaching more than 50 per 
100.000 population each year. The incidence of nasopharyngeal 
carcinoma in Indonesia is quite high, which is around 4.7 new cases per 
100,000 population every year or approximately 7000-8000 cases per 
year throughout Indonesia. Between 2013 and 2016 there were             
506 cases found in the ORL- HNS Department of Medical Faculty 
University of Indonesia-Cipto Mangunkusumo General Hospital. While 
in ORL-HNS Department of Dr. Mohammad Hoesin General Hospital 
Palembang in 2013-2017,  284 cases were found [6, 7]. 
Nasopharyngeal carcinoma is mainly found in men of productive 
age with a comparison of male and female patients of 2,18: 1 and 60% 
of patients aged between 25 and 60 years. NPCs are very rarely found 
in adolescents, namely ages 11 to 21 years. Another problem in the 
management of NPC is the emergence of cases that occur at a young 
age which is thought to be due to unhealthy lifestyles such as childhood 
exposure to cigarette smoke, consumption of ready-to-serve foods with 
many artificial flavorings, coloring and preservatives or other 
carcinogens. The study of the Age Standardized Rate (ASR) and Age 
Standardized Cancer Ratio (ASCAR) of NPC at Dr. Kariadi 
Hospital Semarang in 2002-2011 showed a consistent year-to-year 
increase, accompanied by an increase in NPC cases at the age of 
under 20 years [8-10,17]. 
2. MATERIAL AND METHODS 
This is a retrospective descriptive study. Data were obtained from 
medical records of nasopharyngeal carcinoma patients in adolescence 
at ORL-HNS Department of Dr. Mohammad Hoesin General Hospital 
Palembang. The sample was collected by consecutive sampling with the 
criteria of all nasopharyngeal carcinoma- prone patients aged 11 to 21 
years. This study describes the patient demographic data which includes 
the number and sex of the patient and also the histopathology, T size, 
nodule size, stage and distant metastases, and therapeutic response. This 
study was aimed to determine the characteristics of nasopharyngeal 
carcinoma in adolescent patients at ORL-HNS Department of Dr. 
Mohammad Hoesin General Hospital Palembang and expected that the 
results might give the baseline for the following study. The results are 
presented descriptively in the form of narratives and tables.  
3. RESULT 
Based on the medical records of ORL-HNS Department of Dr. 
Mohammad Hoesin General Hospital Palembang, the number of 
adolescent patients with nasopharyngeal carcinoma in January 2013 to 
December 2017 was 12 patients. In this report out of 12 patients, 8 were 
male (66,7%) and 4 (33,3%) were female. The distribution of 














Table 1. The Distribution of Nasopharyngeal Carcinoma Patients 
Data n % 
Sex   
Male 8 66.7 
Female 4 33.3 
Age   
14 1 8.33 
15 1 8.33 
17 1 8.33 
18 2 16.6 
19 3 25 
20 4 33.3 
Histopathological features   
WHO 1  1 8.33 
WHO 2A 3 25 
WHO 2B 6 50 
WHO 3 2 16.6 
Tumor   
T1 1 8.33 
T2 2 16.6 
T3 4 33.3 
T4 5 41.6 
Nodules   
N0 1 8.33 
N1 3 25 
N2 1 8.33 
N3 7 58.3 
Stage   
I 1 8.33 
II 2 16.6 
III 4 33.3 
IV 5 41.6 
Condition   
Deceased 1 8.33 
Complete response 2 16.6 
Responded to therapy 7 58.3 
Not responded 1 8.33 
Missed follow up 1 8.33 
Total 12           100 
Adolescent patients with nasopharyngeal carcinoma who sought 
treatment were in the group of age ranged from 14 to 20 years.  Age 20 
dominated the adolescent NPC patients with as many as 4 patients  
(33,3%),  followed  by  age   19   (3 patients, 25%), age 18 (2 patients, 
16,6%), age 17, 15, and 14 respectively 1 patient (8,33%). The age 
distribution of adolescent nasopharyngeal carcinoma patients based on 
age can be seen in Table 1. 
Based on histopathological features, the highest number of adolescent 
nasopharyngeal carcinoma patients was WHO 2B nasopharyngeal 
carcinoma of 6 patients (50%). Furthermore, the most histopathological 
view of nasopharyngeal carcinoma was WHO 2A with 3 patients (25%) 
followed by WHO 3 and WHO 1 (2 patients, 16,6% and 1 patient, 8,33%, 
respectively). Distribution of adolescent nasopharyngeal carcinoma 
patients based on histopathological features can be seen in Table 1. 
From the description of computed tomography for the location of the 
tumor, the highest number was T4 tumors with as many as 5 patients 
(41,6%), followed the T3 tumors (4 patients, 33,3%), T2 (2 patients, 
16,6%), and the last was T1 with 1 patient (8,33%). Distribution of tumor 
images based on computer tomography can be seen in Table 1. 
Based on the description of neck lymph node metastasis, obtained 
from this report the most common nodules were N3 nodules of 7 patients 
(58,3%). Furthermore, most of the N1 nodules were 3 patients (25%), N0 
and N2 respectively 1 patient (8,33%). The distribution of adolescent 
nasopharyngeal carcinoma patients based on neck lymph node nodules 
can be seen in Table 1. 
In this report, the majority of patients were stage IV nasopharyngeal 
carcinoma (5 patients, 41,6%). There were 4 patients (33,3%) with stage III 
nasopharyngeal carcinoma; 2 patients (16,6%) had stage II nasopharyngeal 
carcinoma and only 1 patient (8,33%) showed stage I nasopharyngeal 
carcinoma. The distribution of adolescent nasopharyngeal carcinoma 
patients based on their stage can be seen in Table 1. 
Based on the response and the condition of the patient to therapy, 
nasopharyngeal carcinoma patients currently die as many as 1 patient 
(8,33%). A number of 2 patients (16,6%) responded completely and down 
to stage T0N0M0, as many as 7 patients (58,3%) experienced progress 
intherapy, 1 patient (8,33%) did not respond to therapy and 1 patient 
(8,33%) did not show up for follow up. Distribution of adolescent 
nasopharyngeal carcinoma patients based on the response to therapy in 
Table 1 in Condition line. 
4. DISCUSSION 
Nasopharyngeal carcinoma is mainly found in men of productive age 
with a comparison of male and female patients of 2,18: 1 and 60% of 
patients aged between 25 and 60 years. NPCs are very rarely found in 
adolescents, namely ages 11 to 21 years. In the ORL-HNS Department of 
Dr. Mohammad Hoesin General Hospital Palembang in the period of 
2013-2017 were found 284 cases. In this report, the number of adolescent 
nasopharyngeal carcinoma patients was 12 patients. Amelia et al. from the 
Department of Pediatrics of Cipto Mangunkusumo General Hospital from 
2005 until 2009 found 24 people with NPC with an age range of 7-17 
years old. The high percentage of NPC at such a young age is estimated 
to be related to genetic factors and also frequently exposed to 
carcinogenic substances from the environment [11, 12, 16]. In this report, 
it was found that nasopharyngeal carcinoma was more common in men 
than women in a ratio of 2:1. 
According to a study conducted by Adham M et al., it was suggested 
that nasopharyngeal carcinoma was more prevalent among men than 
women with a ratio of  2-3:1. This explains a little bit that nasopharyngeal 
carcinoma is influenced by sex. This may be because several leading 
factors of nasopharyngeal carcinoma are often found in men, such as 
smoking, drinking alcohol, and exposure to wood dust [13, 14]. 
In this report, the most common histopathological features of 
nasopharyngeal carcinoma were WHO IIB types (6 patients). The 
research conducted by Yenita et al in West Sumatra found that 
histopathological findings of nasopharyngeal carcinoma largely were 
WHO IIB. The WHO IIB depiction has a better prognosis. In this report, 
the highest number of patient's computed tomography imaging was T4 (5 
patients). Hidden nasopharyngeal sites and unusual symptoms often make 
patients have a consultation when the tumor is already in a larger state. 
From the picture of the neck lymph node nodules, it was found that the 
majority of patients with N3 lymph node enlargement with as many as 7 
patients. Painless and slowly growing neck lymph nodes often make 
patients ignore complaints from the neck. Hence, patients came when they 
were already in an advanced stage.6,8 
In this report, 5 patients arrived with stage IV, 4 patients with stage 
III, 2 patients came with stage II, and 1 patient with stadium. In a study 
conducted by Li et al, patients came in as much as 42.25%. . Factors of 
ignorance of patients, where the nasopharynx is hidden, symptoms that 
are not typical of nasopharyngeal carcinoma often make patients come 
already in an advanced stage. In addition, symptoms of lumps that are felt 
painless often make patients ignore the disease [7, 15].  
5. CONCLUSION 
Based on the results from the study and discussion, it can be 
concluded that the patients of nasopharyngeal carcinoma in adolescence 
with an age range of 11-21 years who came to the ORL-HNS Department 
of Dr. Mohammad Hoesin General Hospital Palembang during  January 
2013 To December 2017 were as many as 12 patients with a male to 
female ratio of 2:1; most cases occurred at the age of 20 years. The most 
seen histopathological features were WHO 2B (6 patients, 50%). The 
tumor size was mostly T4 (5 patients, 41,6%). The size of the most 
nodules was N3 in 7  patients (58,3%). Most patients presen Based on the 
results from the study and discussion, it can be concluded that the patients 
of nasopharyngeal carcinoma in adolescence with an age range of 11-21 
years who came to the ORL-HNS Department of Dr. Mohammad Hoesin 
General Hospital Palembang during  January 2013 To December 2017 
were as many as 12 patients with a male to female ratio of 2:1; most cases 
occurred at the age of 20 years. The most seen histopathological features 
were WHO 2B (6 patients, 50%). The tumor size was mostly T4 (5 
patients, 41,6%). The size of the most nodules was N3 in 7 patients 
(58,3%). Most patients presented in stage IV (5 patients, 41,6%). 
Adolescent nasopharyngeal carcinoma patients showed a response to 
good therapy as many as 7 patients (58,3%) in stage IV (5 patients, 
41,6%). Adolescent nasopharyngeal carcinoma patients showed a 











[1] Soetirto I, Hendarmin H, Bashiruddin J. Buku Ajar Ilmu Kesehatan Telinga 
Hidung Tenggorok Kepala dan Leher. Edisi Keenam. Soepardi EA, 
Iskandar N, Bashiruddin J, Restuti RD, editor. Gangguan Pendengaran dan 
Kelainan Telinga Jakarta: Balai Penerbit FKUI. 2007;10. 
[2] Wei W, Chua D. Nasopharyngal cancer. Dalam Bailey BJ, Healey GB, Johnson 
JT, Rosen CA dkk, penyunting. Head and neck surgeryotolaryngology 
Philadelphia Lippincott Williams & Wilkins Edisi ke-4. 1875;97. 
[3] Fachiroh J, Schouten T, Hariwiyanto B, Paramita DK, Harijadi A, Haryana SM, et 
al. Molecular diversity of Epstein-Barr virus IgG and IgA Antibody Responses in 
Nasopharyngeal Carcinoma: A Comparison of Indonesian, Chinese, And 
European Subjects. The Journal of Infectious Diseases. 2004:53-62. 
[4] Sriamporn S, Vatanasapt V, Pisani P, Yongchaiyudha S, Rungpitarangsri V. 
Environmental Risk Factors for Nasopharyngeal Carcinoma: A Case-
Control Study in Northeastern Thailand. Cancer Epidemiology and 
Prevention Biomarkers. 1992;1(5):345-8.  
[5] Asri A. Korelasi antara Latent Membrane Protein-1 Virus Epstein-Barr 
dengan P53 pada Karsinoma Nasofaring (Penelitian Lanjutan). Jurnal 
Kesehatan Andalas. 2012;1(1). 
[6] Chan A, Grégoire V, Lefebvre J-L, Licitra L, Felip E, Group EEEgw. Nasopharyngeal 
Cancer: EHNS–ESMO–ESTRO Clinical Practice Guidelines for Diagnosis, 
Treatment and Follow-Up. Annals of Oncology. 2010;21(suppl_5):v187-v9. 
[7] Chang ET, Adami H-O. The Enigmatic Epidemiology of Nasopharyngeal Carcinoma. 
Cancer Epidemiology and Prevention Biomarkers. 2006;15(10):1765-77. 
[8] Ballenger JJ. Tumor dan Kista di Muka, Faring dan Nasofaring dalam 
Penyakit Telinga, Hidung, Tenggorok Kepala dan Leher, Jilid 1, Alih 
Bahasa Staf Ahli Bagian THT RSCM FK-UI,   Indonesia. Binarupa Aksara 
Publisher, p 359-396. 
[9] Sim EU-H, Toh AK-L, Tiong T-S. Preliminary Findings of Down-
Regulated Genes in Nasopharyngeal Carcinoma. Asia Pacific Journal of 
Molecular Biology and Biotechnology. 2008;16(3):79-84. 
[10] Ariwibowo H. Faktor Risiko Karsinoma Nasofaring. Cermin Dunia 
Kedokteran. 2013;40(5):348-51. 
[11] Muna NI. Hubungan Paparan Debu Kayu dan Formaldehid dengan Faktor 
Risiko Terjadinya Karsinoma Nasofaring (Studi Observasional pada Pasien 
Keganasan Kepala Leher di Klinik Telinga Hidung Tenggorok-Bedah Kepala 
dan Leher RS. Dr. Kariadi Periode 1 April 2008-15 Juni 2008). Universitas 
Diponegoro. 2008;1-26. 
[12] Cempako G, Windiastuti E. Karsinoma Nasofaring pada Anak: Karakteristik, 
Tata Laksana dan Prognosis. Sari Pediatri. 2016;13(1):79-84. 
[13] Bray F, Haugen M, Moger TA, Tretli S, Aalen OO, Grotmol T. Age-Incidence 
Curves of Nasopharyngeal Carcinoma Worldwide: Bimodality in Low-Risk 
Populations and Aetiologic Implications. Cancer Epidemiology and Prevention 
Biomarkers. 2008;17(9):2356-65. 
[14] Lu JJ, Grégoire V, Lin S. Selection and Delineation of Target Volumes in 
Intensity-Modulated Radiation Therapy for Nasopharyngeal Cancer.  
Nasopharyngeal Cancer: Springer; 2010. p. 213-32. 
[15] Marlinda A, Andriastuti M, Irwan, Lisnawati, Ukhrowiyah Y. Diagnosis 
dan Penatalaksanaan Karsinoma Nasofaring pada Anak. Case report. 
Universitas Indonesia. 2010;1-14 
[16] Tirtosastro S, Murdiyati A. Kandungan Kimia Tembakau dan Rokok. 
Buletin Tanaman Tembakau, Serat & Minyak Industri. 2017;2(1):33-44. 
[17] Firdaus MA, Prijadi J. Kemoterapi Neoadjuvan pada Karsinoma 
Nasofaring. Universitas Andalas. 2009;1-11 
 
13 
